Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$0.91 0.04 (4.28%) as of 4:30 Wed 6/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 126.22(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8537 - $4.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 3,834 34,841 57,218 116,663
Total Sell Value $3,726 $44,583 $128,469 $435,194
Total People Sold 1 4 5 9
Total Sell Transactions 1 9 12 23
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 940
  Page 33 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Finer Mitchell H. Chief Scientific Officer   •       –      –    2014-10-08 4 OE $2.09 $72,143 D/D 34,518 15,926     -
   Gillis Steven Director   –       •      –    2014-10-07 4 S $35.15 $235,505 I/I (6,700) 1,156,111     -
   Gillis Steven Director   –       •      –    2014-10-06 4 S $35.16 $847,356 I/I (24,100) 1,162,811     -
   Gillis Steven Director   –       •      –    2014-10-03 4 S $35.74 $951,935 I/I (26,635) 1,186,911     -
   Gillis Steven Director   –       •      –    2014-10-02 4 S $34.87 $1,658,208 I/I (47,554) 1,213,546     -
   Leschly Nick President and CEO   •       •      –    2014-10-01 4 AS $34.55 $276,400 D/D (8,000) 307,070     -
   Davidson David Chief Medical Officer   •       –      –    2014-10-01 4 AS $34.55 $103,650 D/D (3,000) 0     -
   Davidson David Chief Medical Officer   •       –      –    2014-10-01 4 OE $2.09 $6,270 D/D 3,000 3,000     -
   Gillis Steven Director   –       •      –    2014-10-01 4 S $34.75 $400,181 I/I (11,516) 1,261,100     -
   Gillis Steven Director   –       •      –    2014-09-30 4 S $36.08 $1,157,988 I/I (32,095) 1,272,616     -
   Tepper Robert I Director   –       •       •   2014-09-12 4 S $36.59 $1,390,420 I/I (38,000) 1,215,054     -
   Trv Gp, Llc 10% Owner   –       –       •   2014-09-12 4 S $36.59 $1,390,420 D/D (38,000) 1,215,054     -
   Tepper Robert I Director   –       •       •   2014-09-11 4 A $0.00 $0 D/D 11,449 26,538     -
   Tepper Robert I Director   –       •       •   2014-09-11 4 D $0.00 $0 I/I (1,155,982) 0     -
   Tepper Robert I Director   –       •       •   2014-09-11 4 A $0.00 $0 I/I 79,062 79,062     -
   Tepper Robert I Director   –       •       •   2014-09-11 4 S $36.52 $3,177,240 I/I (87,000) 2,329,974     -
   Trv Gp, Llc 10% Owner   –       –       •   2014-09-11 4 D $0.00 $0 D/D (1,155,982) 0     -
   Trv Gp, Llc 10% Owner   –       –       •   2014-09-11 4 A $0.00 $0 D/D 79,062 79,062     -
   Trv Gp, Llc 10% Owner   –       –       •   2014-09-11 4 S $36.52 $3,177,240 D/D (87,000) 2,329,974     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-09-10 4 AS $37.02 $277,650 D/D (7,500) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-09-10 4 OE $2.09 $15,675 D/D 7,500 7,500     -
   Gillis Steven Director   –       •      –    2014-09-08 4 A $0.00 $0 D/D 785 1,222     -
   Gillis Steven Director   –       •      –    2014-09-08 4 D $0.00 $0 I/I (313,877) 1,304,711     -
   Leschly Nick President and CEO   •       •      –    2014-09-02 4/A AS $38.00 $307,800 D/D (8,100) 314,901     -
   Davidson David Chief Medical Officer   •       –      –    2014-09-02 4 AS $38.00 $114,000 D/D (3,000) 0     -
  940 Records found
  Previous  30  31  32  33  34  35  36  37  38   
  Page 33 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us